LIM, JONGWON,REUTERSHAN, MICHAEL, H.,ELLIS, JOHN MICHAEL,CHILDERS, KALEEN KONRAD,DONOFRIO, ANTHONY,ALTMAN, MICHAEL, D.,HAIDLE, ANDREW, M.,ZABIEREK, ANNA,CHRISTOPHER, MATTHEW,GRIMM, JONATHAN,BURCH, JAS
申请号：
EP13807108
公开号：
EP2863913A4
申请日:
2013.06.18
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention provides novel imidazole analogs of Formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.
